Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (541-550 of 710) with videos related to

Pageof 71
Sort By:
JHEP Reports : Innovation in Hepatology|February 21, 2025
Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndromeFabien Robert, Feriel Benchenouf, My Ngoc Ha, et al.
American Journal of Hematology|June 18, 2021
Cardiovascular phenotypes predict clinical outcomes in sickle cell disease: An echocardiography-based cluster analysisThomas d'Humières, Laurent Savale, Jocelyn Inamo, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Clinical and Experimental Rheumatology|June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosisDoerte Huscher, David Pittrow, Oliver Distler, et al.
Annals of the Rheumatic Diseases|May 16, 2025
Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15Athénaïs Boucly, Stéphane Mitrovic, Maryvonnick Carmagnat, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
The European Respiratory Journal|December 23, 2018
Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult casesMélanie Eyries, David Montani, Sophie Nadaud, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 14, 2021
Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in FranceJérôme Le Pavec, Séverine Feuillet, Olaf Mercier, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
The European Respiratory Journal|November 7, 2015
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive diseaseDavid Montani, Edmund M Lau, Alexis Descatha, et al.
Pageof 71

Showing results (541-550 of 710) with videos related to

Sort By:
Pageof 71
JHEP Reports : Innovation in Hepatology|February 21, 2025
Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndromeFabien Robert, Feriel Benchenouf, My Ngoc Ha, et al.
American Journal of Hematology|June 18, 2021
Cardiovascular phenotypes predict clinical outcomes in sickle cell disease: An echocardiography-based cluster analysisThomas d'Humières, Laurent Savale, Jocelyn Inamo, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Clinical and Experimental Rheumatology|June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosisDoerte Huscher, David Pittrow, Oliver Distler, et al.
Annals of the Rheumatic Diseases|May 16, 2025
Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15Athénaïs Boucly, Stéphane Mitrovic, Maryvonnick Carmagnat, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
The European Respiratory Journal|December 23, 2018
Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult casesMélanie Eyries, David Montani, Sophie Nadaud, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 14, 2021
Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in FranceJérôme Le Pavec, Séverine Feuillet, Olaf Mercier, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
The European Respiratory Journal|November 7, 2015
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive diseaseDavid Montani, Edmund M Lau, Alexis Descatha, et al.
Pageof 71